Abstract:Background Previous studies have shown that miR-100-5p expression is abnormal in prostate cancer. However, the role and regulatory mechanism of miR-100-5p requires further investigation. Thus, the aim of this study was to observe the effects of miR-100-5p on the proliferation, migration and invasion of prostate cancer (PCa) cells and to explore the potential related regulatory mechanism. Materials and Methods Differential miRNA expression analysis was performed using next-generation sequencing (NGS) in the patients with PCa and benign prostatic hyperplasia (BPH). The expression levels of miR-100-5p were detected using real-time fluorescence quantitative PCR (qRT-PCR). PCa cells were transfected with NC-mimics or miR-100-5p mimics, inhibitor by using liposome transfection. Moreover, the CCK-8 proliferation assay, colony formation assay, cell scratch assay and Transwell assay were used to detect the effects of miR-100-5p on cell proliferation, migration, and invasion. In addition, the target gene of miR-100-5p was verified by luciferase reporter gene assay, and the influence of miR-100-5p on the expression of mTOR mRNA by qRT-PCR and the expression of mammalian target of rapamycin (mTOR) protein was detected by western blot and immunohistochemical staining. Results Differential expression analysis of high-throughput sequencing data showed low expression of miR-100-5p in the patients of PCa. It was further confirmed by qRT-PCR that the expression of miR-100-5p in PCa cells was significantly lower than that in RWPE-1 cells ( P <0.01). miR-100-5p expression in lymph node carcinoma of prostate(LNCaP) cells was markedly upregulated after transfection with miR-100-5p mimics ( P <0.01), while cell proliferation, migration and invasion capacities were clearly reduced ( P <0.01). mTOR mRNA and protein expression was also substantially lowered ( P <0.01) and mTOR adjusted the expression of NOX4. Finally, we further confirmed by immunohistochemical staining that miR-100-5p regulated the expression of mTOR and NOX4. Conclusion miR-100-5p is expressed at low levels in PCa cells, and it can suppress PCa cell proliferation, migration and invasion, the mechanism of which is related to downregulating the expression of mTOR.

Low Expression of Microrna-30C Promotes Prostate Cancer Cells Invasion Involved in Downregulation of KRAS Protein.

Mirna-30A Functions As a Tumor Suppressor by Downregulating Cyclin E2 Expression in Castration-Resistant Prostate Cancer.

MicroRNA-30e Inhibits Adhesion, Migration, Invasion and Cell Cycle Progression of Prostate Cancer Cells Via Inhibition of the Activation of the MAPK Signaling Pathway by Downregulating CHRM3

The Putative Tumor Suppressor Microrna-30A-5p Modulates Clear Cell Renal Cell Carcinoma Aggressiveness Through Repression of ZEB2

miR-100-5p Downregulates mTOR to Suppress the Proliferation, Migration, and Invasion of Prostate Cancer Cells

Mir-1231 is Downregulated in Prostate Cancer with Prognostic and Functional Implications

SOX30, a Target Gene of Mir-653-5p, Represses the Proliferation and Invasion of Prostate Cancer Cells Through Inhibition of Wnt/β-catenin Signaling

RETRACTED ARTICLE: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.

MicroRNA-19a-3p Suppresses Invasion and Metastasis of Prostate Cancer Via Inhibiting SOX4.

MicroRNA-335 Acts As a Candidate Tumor Suppressor in Prostate Cancer.

Mir-30C Suppresses Prostate Cancer Survival by Targeting the ASF/SF2 Splicing Factor Oncoprotein

miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway.

Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1

miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4

Microrna-330 Inhibits Cell Motility By Downregulating Sp1 In Prostate Cancer Cells

MicroRNA-193a-3p Inhibits Cell Proliferation in Prostate Cancer by Targeting Cyclin D1

MicroRNA-181b Expression in Prostate Cancer Tissues and Its Influence on the Biological Behavior of the Prostate Cancer Cell Line PC-3.

MicroRNA181c Inhibits Prostate Cancer Cell Growth and Invasion by Targeting Multiple ERK Signaling Pathway Components

Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism

Suppression of Microrna-454 Impedes the Proliferation and Invasion of Prostate Cancer Cells by Promoting N-myc Downstream-Regulated Gene 2 and Inhibiting WNT/β-catenin Signaling